The University Health Network, where "above all else the needs of patients come first", encompasses Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and the Michener Institute of Education. The breadth of research, the complexity of the cases treated, and the magnitude of its educational enterprise has made UHN a national and international resource for patient care, research and education. With a long tradition of ground breaking firsts and a purpose of "Transforming lives and communities through excellence in care, discovery and learning", the University Health Network (UHN), Canada's largest research teaching hospital, brings together over 16,000 employees, more than 1,200 physicians, 8,000+ students, and many volunteers. UHN is a caring, creative place where amazing people are amazing the world.
Union: Non-Union
Site: Princess Margaret Cancer Centre
Department: Correlative Studies Program
Reports to: Senior Manager, Correlative Studies Program
Work Model: On-Site
Grade: D0:06
Hours: 37.5 hours per week
Salary: $36.38 to $45.48 per hour (To commensurate with experience and consistent with UHN compensation policy)
Shifts: Day
Status: Permanent Full-time
Closing Date: Until Filled
Position Summary
The Correlative Studies Program (CSP) provides biospecimen management services to facilitate advanced and comprehensive translational cancer research with the overall goal of aiding in discovering new cancer diagnostic and treatment standards. CSP is part of the Cancer Clinical Research Unit (CCRU). The Clinical Research Coordinator I (CRC) will work directly with the Lymphoma and CSP teams at Princess Margaret Cancer Centre. The position will bridge the lymphoma clinics and the translational research lab in the MaRS building.
The Clinical Research Coordinator I (CRC) will be responsible for accruing patients to translational research studies. This includes explaining the study protocol to patients, answering questions, reviewing inclusion/exclusion criteria, and documenting the informed consent process. Other responsibilities include reviewing protocols, creating study-specific materials and workflows, tracking biospecimens collected, issuing and resolving queries, attending regular team meetings, and keeping trackers and biospecimen inventory current. The CRC will collaborate with investigators, clinical research nurses, and other healthcare professionals, including the BMT cell therapy coordinators, to jointly assume responsibility for the frontline management and coordination of non-therapeutic oncology trials while integrating the research studies into standard-of-care therapies.
Duties
Why join UHN?
In addition to working alongside some of the most talented and inspiring healthcare professionals in the world, UHN offers a wide range of benefits, programs and perks. It is the comprehensiveness of these offerings that makes it a differentiating factor, allowing you to find value where it matters most to you, now and throughout your career at UHN.
Current UHN employees must have successfully completed their probationary period, have a good employee record along with satisfactory attendance in accordance with UHN's attendance management program, to be eligible for consideration.
All applications must be submitted before the posting close date.
UHN uses email to communicate with selected candidates. Please ensure you check your email regularly.
Please be advised that a Criminal Record Check may be required of the successful candidate. Should it be determined that any information provided by a candidate be misleading, inaccurate or incorrect, UHN reserves the right to discontinue with the consideration of their application.
UHN is an equal opportunity employer committed to an inclusive recruitment process and workplace. Requests for accommodation can be made at any stage of the recruitment process. Applicants need to make their requirements known.
We thank all applicants for their interest, however, only those selected for further consideration will be contacted.